Status:
COMPLETED
Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Prolonged Air Leak
Postoperative Air Leak
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Postoperative prolonged air leak (PAL), referring to the passage of air from the lung parenchyma into the pleural space, is one of the most frequent postoperative complications after lung resection. T...
Eligibility Criteria
Inclusion
- Patients with a pulmonary air leak following open lung surgery, regardless of whether an anatomical or atypical resection was performed
- Patients who are able to decide for themselves whether to participate in the study or not ( for example due to language problems, mental disorders, dementia of the participant)
- Patients who are not family member or employee of the investigator
Exclusion
- Inability to follow the procedures of the study, for example, due to language problems, mental disorders, dementia of the participant
- Enrolment of the investigator, his/her family members, employees and other dependent persons
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04065880
Start Date
April 1 2020
End Date
July 31 2021
Last Update
May 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Thoracic Surgery, University Hospital Basel
Basel, Switzerland, 4031